Frontiers | Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson's Disease: A Perspective Through Preclinical and Clinical Evidence
Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
PDF) Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation
Levodopa-Induced Dyskinesia in Parkinson's Disease
PDF) Levodopa-induced plasticity: A double-edged sword in Parkinson's disease
Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone
PDF) Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease
Evaluation of Levodopa Dose and Magnitude of Dopamine Depletion as Risk Factors for Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease | Journal of Pharmacology and Experimental Therapeutics
Investigating The Acute Levodopa Response In Early To Advanced Parkinson's Disease
Review Article Clinical Aspects and Management of Levodopa-Induced Dyskinesia
The human experience with intravenous levodopa
PDF) Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease
Time course for AIM scores following levodopa. Rats were treated daily... | Download Scientific Diagram
Current Knowledge on the Background, Pathophysiology and Treatment of Levodopa-Induced Dyskinesia— Literature Review
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs | Nature Reviews Drug Discovery
Download PDF | Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library
![PDF] Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease](https://i1.rgstatic.net/publication/320469061_LevodopaBenserazide_Loaded_Microspheres_Alleviate_L-dopa_Induced_Dyskinesia_through_Preventing_the_Over-Expression_of_D1RShp-2ERK12_Signaling_Pathway_in_a_Rat_Model_of_Parkinson's_Disease/links/59e752f24585152d5f04deb6/largepreview.png "PDF] Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease")
PDF] Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease
Biomolecules | Free Full-Text | Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease | HTML
Levodopa-Induced Dyskinesia in Parkinson Disease: Current and Evolvin…
Profile of levodopa/carbidopa intestinal gel and its potential in the | JPRLS
PDF) Profile of levodopa/carbidopa intestinal gel and its potential in the treatment of advanced Parkinson's disease
Frontiers | The Human Experience with Intravenous Levodopa
PDF) Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease
